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SUMMARY.Barrett’s esophagus (BE) is a metaplastic condition of the distal esophagus, resulting from longstand-
ing gastroesophageal reflux disease (GERD). BE predisposes for the highly malignant esophageal adenocarcinoma
(EAC). Both BE and EAC have the highest frequencies in white males. Only a subset of patients with GERD develop
BE, while <0.5% of BE will progress to EAC. Therefore, it is most likely that the development of BE and EAC
is associated with underlying genetic factors. We hypothesized that in white males, Y-chromosomal haplogroups
are associated with BE and EAC. To investigate this we conducted a multicenter study studying the frequencies
of the Y-chromosomal haplogroups in GERD, BE, and EAC patients. We used genomic analysis by polymerase
chain reaction and restriction fragment length polymorphism to determine the frequency of six Y-chromosomal
haplogroups (DE, F(xJ,xK), K(xP), J, P(xR1a), and R1a) between GERD, BE, and EAC in a cohort of 1,365
white males, including 612 GERD, 753 BE patients, while 178 of the BE patients also had BE-associated EAC.
Univariate logistic regression analysis was used to compare the outcomes. In this study, we found the R1a (6% vs.
9%, P = 0.04) and K (3% vs. 6%, P = 0.035) to be significantly underrepresented in BE patients as compared to
GERD patients with an odds ratio (OR) of 0.63 (95% CI 0.42–0.95, P = 0.03) and of 0.56 (95% CI 0.33–0.96,
P= 0.03), respectively, while the K haplogroup was protective against EAC (OR 0.30; 95%CI 0.07–0.86,P= 0.05).
A significant overrepresentation of the F haplogroup was found in EAC compared to BE and GERD patients (34%
vs. 27% and 23%, respectively). The F haplogroup was found to be a risk factor for EAC with an OR of 1.5 (95%
CI 1.03–2.19, P = 0.03). We identified the R1a and K haplogroups as protective factors against development of
BE. These haplogroups have low frequencies in white male populations. Of importance is that we could link the
presence of the predominantly occurring F haplogroup in white males to EAC. It is possible that this F haplogroup
is associated to genetic variants that predispose for the EAC development. In future, the haplogroups could be
applied to improve stratification of BE and GERD patients with increased risk to develop BE and/or EAC.
KEYWORDS: Barrett’s esophagus, esophageal adenocarcinoma, gastroesophageal reflux disease, genetic
polymorphisms, Y-chromosome haplogroup.
1
D
ow
nloaded from
 https://academ
ic.oup.com
/dote/article/33/9/doaa011/5780184 by Erasm
us U
niversity R
otterdam
 user on 16 O
ctober 2020
2 Diseases of the Esophagus
INTRODUCTION
Barrett’s esophagus (BE) is a condition caused by
chronic gastroesophageal reflux disease (GERD),1–4
in which the normal squamous mucosa of the distal
esophagus is substituted by a specialized (intestinal)
columnar type of epithelium. BE is most prevalent in
older white males. BE patients are at an increased risk
for developing esophageal adenocarcinoma (EAC).5
Besides age, ethnicity, and male gender, risk fac-
tors for GERD patients to develop BE are less clear.
Apparently, the development of BE and EACdepends
on a combination of lifestyle factors6–12 and a genetic
predisposition. The efforts to find specific genetic
abnormalities that are associated with development
of BE and progression of BE to EAC are ongoing.13
For example, a study by Sun et al. found an increased
admixture of European ancestry on chromosome 8
and 11 in African American patients.14 These chro-
mosomal regions contain several candidate genes that
have been suggested to be involved in the development
of BE and EAC. A particular other genetic change
that has been observed in nondysplastic BE is numer-
ical Y-chromosome abnormalities.15–17
Relevant features of the Y chromosome include the
haploid status and the inability of the Y chromosome
to recombine over most of its length (male-specific
region [MSY]). Therefore, the MSY region is trans-
mitted unchanged from father to the male offspring
over many generations.
Genotyping for Y-chromosomal polymorphic
markers located on this MSY region of the chro-
mosome, makes it possible to define Y haplogroups,
which for example has been used to track human
evolution and migration but can also be applied
to investigate an association between genes on the
Y chromosome and certain diseases as well as
potential role of ethnicity on the development of these
particular diseases.18,19
In this study, we hypothesized that certain
Y-chromosomal haplogroups are associated with an
increased susceptibility for BE and EAC. To test our
hypothesis, we used a set of six Y-chromosome-linked
polymorphisms to define the major Y-chromosome
haplogroups in white males with BE or BE-associated
EAC. Their Y-chromosome haplogroup frequencies
were subsequently compared to white males with
GERD symptoms that had no BE at endoscopy.
MATERIAL ANDMETHODS
Study population
This multicenter case control study was approved by
all the local ethics committees and all participants
agreed to the use of their samples. The total cohort
consisted of 1,445 Dutch and US patients (Fig. 1). Of
these, 51 were excluded due to insufficient material in
the paraffin embedded tissue blocks that were used for
DNA extraction. Another 24 patients were excluded
because of technical reasons (i.e. the DNA concen-
tration was too low for polymerase chain reaction
[PCR] or PCR results were inconsistent). Finally, five
patients were excluded because of their Y chromo-
some falling into the A, B, or C haplogroups which
are haplogroups associated with African descent. The
Dutch patients underwent upper gastrointestinal (GI)
endoscopy between 2002 and 2006 in the Amsterdam
University Medical Centers (AUMC, Amsterdam
and the Erasmus Medical Center (EMC, Rotterdam).
Data on ethnic origin for all individuals were obtained
from patient files and/or by questionnaires. The
US patients underwent upper GI endoscopy at the
Mayo Clinic, Rochester, USA between 1992 and
2010. White ethnic origin of these patients was
confirmed using both questionnaires as well as patient
charts. GERD was classified according to the Los
Angeles (LA) classification. Patients with GERD
symptoms (objectified using either a questionnaire
or pH-metry) but with no visible reflux esophagitis
were classified as nonerosive GERD (grade 0).
For histological confirmation of BE, biopsies were
taken below the z-line in the esophagus and at least
1 cm above the gastric folds from the BE mucosa. In
case of EAC, biopsies were taken from the tumormass
and adjacent to the mass to confirm BE-associated
EAC. Active reflux esophagitis was classified accord-
ing to the LA classification.
Y-chromosome haplotyping
Genomic DNA of each patient was extracted from
normal GI tissue (Qiagen) or from a whole blood
sample by standard salt-out procedure. Six Y-linked
binary markers, located on the male-specific region
of the Y chromosome and known to be polymor-
phic in the European population, were chosen to
genotype all individuals using the following markers:
M9, SRY10831, M89, DYS257, Yap, and p12f.20,21
Genotyping was performed by the PCR and restric-
tion fragment length polymorphism and is further
described in the Supplementary Data.
Statistical analysis
Differences in the distribution of the Y-chromosomal
haplogroups were determined with Pearson chi-
square test (two sided). To assess the predictive power
of Y haplogroups on group allocation (odds ratios
[ORs]), a univariate logistic regression, using the P
haplogroup as a reference group, was performed.
Confounding by variables such as familial relation-
ship, ethnicity, or gender was excluded due to the
strict patient selection. Multivariate analysis was
performed to adjust for age. Statistical significance
was set at a P value of <0.05. Data analysis was
performed using R statistical software version 3.5.1.
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Fig. 1 Flow chart of included patients.
RESULTS
BE and GERD patients
The final cohort consisted of 1,365 patients: 753
BE and 612 GERD. The population consisted of
646 white male patients from the Netherlands (183
GERD, 463 BE) and 719 from the United States (429
GERD, 290 BE) (Fig. 1).
The GERD group consisted of 183 Dutch (all
AUMC) and 429 US patients, with a mean age of
55± 15 (mean in years ± SD) and served as a white
male control group of patients without BE. In the
GERD group 58 patients (10%) had grade 0; 463
(76%) patients had gradeA/B and 83 (14%) of patients
had grade C/D reflux esophagitis.
The BE group consisted of 463 Dutch (235 AUMC
and 228 Erasmus MC) and 290 US white males. All
patients had histologically proven BE. Mean age was
62± 12 (mean in years± SD). There was a significant
difference in age between the GERD and BE group of
55 versus 62 years (P < 0.001) (Table 1).
Patients with BE-associated EAC versus BE patients
without EAC
One hundred and seventy eight of 753 BE patients
(24%) had BE-associated EAC. Mean age for these
patients was 65± 12 (mean in years ± SD) versus
62± 13 in the patients that had BE without EAC,
P =0.004.
Overall haplogroup frequencies in the study cohort
The haplogroups most frequently observed were the
P and F haplogroups. Approximately 80% of the
patients fell within these two haplogroups whereas
the DE, J, R1a, and K haplogroups were found less
frequently (Table 2).
Differences between the BE (with or without EAC)
versus GERD patients
In this study cohort, a significant difference was
observed in the overall distribution of Y haplogroups
between the BE with EAC (BE/EAC) (n =753)
and the GERD (n =612) population (P =0.02;
Table 3). This was in part due to the fact that the R1a
haplogroup—using the P haplogroup as a reference
haplogroup—was significantly underrepresented
in the BE/EAC group compared to the GERD
group (6% vs. 9%, OR of 0.63 [0.41–0.95 95% CI,
P =0.03]). Also, the frequency of the K haplogroup
was significantly lower in the BE/EAC group than in
the GERD group (3% vs. 6%) corresponding to lower
odds to have BE/EAC, with an OR of 0.56 (95% CI
0.33–0.96, P =0.03) compared to the P haplogroup.
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Table 1 Patient characteristics
Patient characteristics GERD BE/all BE/EAC
Age (mean± SD) 55± 15 62± 12 65± 12
Weight (BMI)
Normal (<25) 79 (17%) 113 (25%) 24 (28%)
Overweight (25–30) 216 (45%) 202 (44%) 34 (40%)
Obese (>30) 183 (38%) 147 (32%) 27 (32%)
Total 478 462 85
Missing data 134 (22%) 291 (39%) 93 (52%)
LA grade reflux esophagitis
Grade 0 58 (10%)
Grade A/B 463 (77%)
Grade C 54 (9%)
Grade D 29 (5%)
Total 604
Missing data 8 (1%)
BE, Barrett’s esophagus; BMI, body mass index; EAC, esophageal adenocarcinoma; GERD, gastroesophageal reflux disease; LA, Los
Angeles.
Table 2 Haplogroup distribution
BE/all GERD BE/EAC
DE 27 (3.6%) 27 (4.4%) 5 (2.8%)
F (xJ, xK) 200 (26.6%)∗ 139 (22.7%)∗ 61 (34.3%)∗
J 23 (3.1%) 26 (4.3%) 4 (2.3%)
K (xP) 25 (3.3%) 34 (5.6%)# 3 (1.7%)#
R1a 47 (6.2%) 57 (9.3%) 9 (5.1%)
Px (R1a) 431 (57.2%) 329 (53.8%) 96 (53.9%)
Total no. 753 612 178
*,#p < .05
Both of these findings remained significant after
adjusting for age.
Differences between BE-associated EAC versus BE
(without EAC) and GERD patients
To investigate if particular Y haplogroups were asso-
ciated with EAC, we compared the haplogroup fre-
quencies between BE with EAC (BE/EAC) versus
BE without EAC (BE) and the GERD patients. We
observed a significant overrepresentation of the F
haplogroup in patients with EAC as compared to the
BE and the GERD patients (35% vs. 27% and 23%,
respectively). Univariate logistic regression analysis
showed that the F haplogroup was associated with an
increased risk for BE-associated EAC as compared to
BE and GERD patients as demonstrated by an OR
of 1.50 (95% CI 1.03–2.19, P =0.03) and 1.53 (95%
CI 1.05–2.23, P =0.03).
Since GERD is a risk factor for BE and BE
may develop in GERD patients at later age, and
because age by itself is a known risk factor for
EAC,22,23 we adjusted results for age by using
multivariate analysis. After adjusting for age, the
differences became less significant, but there was
still a clear trend (OR 1.42; 95% CI 0.94–2.13,
P =0.09 and OR 1.42; 95% CI 0.96–2.09; P =0.07,
respectively).
We also found that the K haplogroup was present
in lower frequencies in the BE/EAC as compared to
the GERD group (2% vs. 6%, respectively) (Table 3).
This difference was borderline significant in the uni-
variate analysis (OR 0.30; 95%CI 0.07–0.86;P=0.05)
but became highly significant after correcting for age.
Thus, the K haplogroup also seems to protect against
development of BE-associated EAC as indicated by
an OR of 0.23 (95% CI 0.05–0.68, P =0.047).
DISCUSSION
Although GERD is the major risk factor for BE
and EAC, there is also a clear genetic predisposition,
which for instance, accounts for the high incidence in
males compared to females and higher frequencies in
white population.
Here, we performed a genetic association study
to investigate the impact of Y-chromosomal hap-
logroups on the susceptibility to BE and EAC.
We determined the Y-chromosomal haplogroup
distribution in BE patients with and without EAC
as well as in a control group of GERD patients while
controlling for confounding factors such as ethnicity,
familial disposition, and age. The most frequently
observed Y haplogroup (56–60%) in the cohort was
haplogroup P(xR1a). Indeed, this haplogroup is the
most common in Europeans and populations of
European ancestry.24 Haplogroup F(xK, J) was the
second most frequently observed Y haplogroup (23–
31%), which is also in agreement with literature.25,26
Haplogroups DE, J, K(xP), and R1a were observed
to have the lowest frequencies (2–8).
One major finding of our study was that the F
haplogroup, which can be found in approximately one
third of the general white population in Northern
Europe showed a correlation with the development
of EAC suggesting that this, for white male common,
haplogroup might predispose for cancer development
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Table 3 Odds ratios for BE/EAC development associated with different Y haplotypes—univariate analysis
Haplotype BE all vs. GERD BE/EAC vs. GERD BE/EAC vs. BE without EAC
OR (95% CI); P
DE 0.76 (0.44–1.33); 0.34 0.63 (0.21–1.56); 0.36 0.79 (0.26–1.99); 0.65
F (xJ, xK) 1.10 (0.85–1.43); 0.48 1.50 (1.03–2.19); 0.03∗ 1.53 (1.05–2.23); 0.03∗
J 0.68 (.38–1.21); 0.18 0.53 (0.15–1.39); 0.24 0.73 (.21–2.01); 0.58
K (xP) 0.56 (0.33–0.96); 0.03∗ 0.30 (0.07–0.86); 0.05∗ 0.48 (0.11–1.41); 0.24
R1a 0.63 (0.42–0.95); 0.03∗ 0.54 (0.24–1.08); 0.10 0.83 (0.36–1.70); 0.62
Px(R1a) 1 (reference) 1 (reference) 1 (reference)
Total no. 753 vs. 612 178 vs. 612 178 vs. 575
*p < .05
in BE patients. Although, this correlation was less
strong after adjusting for age, there was still a clear
trend after entering yet another degree of freedom
into the model in a subgroup that is already relatively
small.
Other interesting findings were the protective effect
that the K and R1a haplotype seemed to confer for
the development of BE. The difference in suscepti-
bility for BE and EAC development between oriental
countries, Africa, and Europe is thought to be at least
partly due to a distinct genetic background and it is
possible that a higher prevalence of the K and R1a
in these populations has a protective effect for devel-
opment of BE or BE-associated EAC.27–30 It would
be highly interesting to study the frequency of the Y
haplogroups with respect to BE and EAC in different
ethnic groups.
The limitations of this study are that this is a
retrospective study. The possibility of false-positive
results because of the geographical stratification and
ethnical distribution of Y haplogroups must also be
considered.31 To avoid these confounding factors,
the appropriate choice of the control population
(nonblood relatives from the same geographical area
as the disease group) is crucial. This was the case
for both our patient cohorts. The white descent of
the Dutch patients was verified to the third or at
least to the second generation and confirmed by
the absence of A, B, or C haplogroups. Therefore,
the haplogroups associations found in the Dutch
cohort are unlikely to be due to bias caused by
different ethnical background. The US patients were
thoroughly checked by both questionnaires and
medical charts. Nevertheless, in the US subgroup, we
found that <1% of patients were possibly of African
descent, still the overall haplogroup distribution was
very similar between the Dutch and US cohort,
suggesting similar ethnic backgrounds and decreasing
the likelihood of stratification bias. Since we excluded
patients that were genetically related, a bias due to
familial predisposition is highly unlikely.
Another important limitation is the fact that in
recent years, with the development of next generation
sequencing (NSG), the Y-haplotree has undergone
significant revisions. Therefore, the application of
NGS in future studies will allow to further subdivide
the F haplogroup into the G, H, and I haplogroups
which will lead to more specific conclusions.
The mechanism behind the Y-chromosomal
haplogroups influence on the susceptibility to BE
and EAC is not clear. We know, however, that Y
chromosomes from distinct Y haplogroups show
considerable structural variation.32 One hypothesis
might be that Y chromosomes of specific haplogroups
are associated with protection against occurrence of
certain Y-chromosomal rearrangements (deletions
or amplifications) influencing expression of genes
important for BE and EAC development. The
candidate genes on theY chromosome involved in this
process may be those that are expressed ubiquitously
in the body, including, for instance, SRY, ZFY, and
SMCY transcription factors, PRKYprotein kinase or
EIF1AY translational inaction factor. It is however
also possible that Y-chromosomal haplogroups are
associated with functional variants of genes on
autosomal chromosomes.33 Such an association, for
instance, was found between aY-chromosome variant
and the polymorphism on the autosomal gene of
aldosterone synthase in European men with high
blood pressure. In the future, linkage disequilibrium
studies may reveal genetic variants on Y chromosome
itself, for example, the tumor suppressor gene
TMSB4Y, or on autosomal chromosomes.
In summary, this study is the first to report an asso-
ciation of K and R1a Y-chromosomal haplogroups
with a lower susceptibility to BE/EAC in a GERD
population of white males. Furthermore, we found
that in the white males relatively frequently occur-
ring F haplotype was associated with an increased
risk to develop EAC. For a better understanding of
the exact mechanisms underlying these associations
further linkage analysis as well as detailed molecular
studies are needed. Our results, however, indicate that
specific haplogroups might be linked to genetic vari-
ants that protect of, or predispose to BE/EAC devel-
opment. The identification of such genetic variants
in the future may improve our understanding of the
pathogenesis of BE and EAC.
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